CEOi Launches Three Part Podcast Series, “A Breakthrough in Alzheimer’s Diagnostics: Integrating Blood Tests into Clinical Practice” in partnership with Pri-Med

Previous
Previous

The Global CEO Initiative on Alzheimer’s Disease Launches Groundbreaking Alzheimer’s Blood Test Performance Database for Clinicians

Next
Next

FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease